PetVivo Holdings (PetVivo Holdings) Days Sales Outstanding : 51.67 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is PetVivo Holdings Days Sales Outstanding?

PetVivo Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $0.34 Mil. PetVivo Holdings's Revenue for the three months ended in Dec. 2023 was $0.60 Mil. Hence, PetVivo Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 51.67.

The historical rank and industry rank for PetVivo Holdings's Days Sales Outstanding or its related term are showing as below:

PETV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.44 Med: 23 Max: 91.84
Current: 91.84

During the past 13 years, PetVivo Holdings's highest Days Sales Outstanding was 91.84. The lowest was 9.44. And the median was 23.00.

PETV's Days Sales Outstanding is ranked worse than
75.59% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs PETV: 91.84

PetVivo Holdings's Days Sales Outstanding declined from Dec. 2022 (56.90) to Dec. 2023 (51.67).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

PetVivo Holdings Days Sales Outstanding Historical Data

The historical data trend for PetVivo Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetVivo Holdings Days Sales Outstanding Chart

PetVivo Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

91.25

28.08

9.44

17.91

PetVivo Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															56.90	215.09	52.25	44.74	51.67

Competitive Comparison of PetVivo Holdings's Days Sales Outstanding

For the Medical Devices subindustry, PetVivo Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PetVivo Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PetVivo Holdings's Days Sales Outstanding falls into.

PetVivo Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PetVivo Holdings's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (0.003	+	0.087)	/	2 )	/	0.917	*	365
=	0.045					/	0.917	*	365
=	17.91

PetVivo Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.156	+	0.519)	/	2 )	/	0.596	*	365 / 4
=	0.3375					/	0.596	*	365 / 4
=	51.67

PetVivo Holdings (OTCPK:PETV) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

PetVivo Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PetVivo Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

PetVivo Holdings (PetVivo Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PetVivo Holdings Inc (OTCPK:PETV) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

5251 Edina Industrial Boulevard, Edina, MN, USA, 55439

Website

https://www.petvivo.com

PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. A key strategy of the company is to leverage human therapies for the treatment of companion animals cost-effectively and in a timely manner. The accelerated timeline to revenues for veterinary medical devices is a key component of this strategy, which enter the market much earlier than pharmaceuticals and biologics. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of nineteen patents.

Executives

James Rudolph Martin	director	POBOX 53988, IRVINE CA 92619
A.l. Sarroff Fund, Llc	10 percent owner	43 MEADOW WOODS ROAD, GREAT NECK NY 11020
John Spencer Breithaupt	director	3041 W. PASADENA DR., BOISE ID 83705
Robert J Costantino	director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joseph William Jasper	director	201 SOUTH 11TH STREET, UNIT 1030, MINNEAPOLIS MN 55403
John Lai	director, 10 percent owner, officer: CEO	12100 SINGLETREE LANE, SUITE 186, EDEN PRAIRIE MN 55344
Robert James Rudelius	director	6913 ARBOR LANE, MCCLEAN VA 22101
Leslie Anne Coolidge	director	345 OLD SUTTON ROAD, BARRINGTON HILLS IL 60010
Robert J. Folkes	officer: Chief Financial Officer	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Scott Mitchell Johnson	director	475 LAKESHORE UNIT #32, INCLINE VILLAGE NV 89451
James Joseph Martin	director	4400 BISCAYNE BLVD, SUITE # 670, MIAMI FL 33157
Gregory D Cash	director
John Michael Carruth	officer: Acting Chief Financial Officer	4923 RIVER WOOD DR., SAVAGE MN 55439
Sherry Grisewood	director	377 FAIRMOUNT ROAD, CALIFON NJ 07830
David Don Deming	director	16200 45TH STREET SOUTH, AFTON MN 55001